Sunday, February 25, 2024
HomeeuropeEuropean Commission authorizes GSK's HIV prevention drug

European Commission authorizes GSK’s HIV prevention drug

The European Commission has authorized GSK’s HIV-focused unit ViiV Healthcare’s cabotegravir long-acting injectable and tablets, the British drugmaker said on Tuesday.

RELATED ARTICLES

Most Popular